Article Text
Commentary
Redefining mental invasiveness in psychiatric treatments: insights from schizophrenia and depression therapies
Statistics from Altmetric.com
Footnotes
Contributors CWM and JVG were directly involved in the creation of the article and each provided substantial contributions. CWM, as the lead author, was primarily responsible for conceptualising the main thesis, conducting the initial literature review and drafting the manuscript. JVG assisted in the editing of the article and expanding initial ideas, ensuring clarity and coherence in the ideas presented. Both authors agree to be accountable for all aspects of the work submitted.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.
Linked Articles
- Feature article
Read the full text or download the PDF:
Other content recommended for you
- Neuropsychiatric syndromes of multiple sclerosis
- Diagnosis and management of bipolar disorders
- Prevalence and major risk factors of type 2 diabetes mellitus among adult psychiatric inpatients from 2005 to 2018 in Beijing, China: a longitudinal observational study
- Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis
- Management of psychotropic drugs during pregnancy
- Bipolar depression: a review of treatment options
- Review on the current use of antipsychotic drugs in children and adolescents
- Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial
- Prescribing pattern of antipsychotic medication for first-episode psychosis: a retrospective cohort study
- Adjunctive treatment with quetiapine for major depressive disorder: are the benefits of treatment worth the risks?